Inhibition of endoproteolytic cleavage of cytomegalovirus (HCMV) glycoprotein B by palmitoyl-peptidyl-chloromethyl ketone

Virology. 1990 Oct;178(2):617-20. doi: 10.1016/0042-6822(90)90365-x.

Abstract

Endoproteolytic cleavage of glycoprotein B (gB) of human cytomegalovirus (HCMV) is inhibited by palmitoylated peptidyl-chloromethyl ketone (palFAKR-CEK) at concentrations above 30 microM. Inhibitor treatment of HCMV-infected human fibroblasts neither interfered with exposure of gB on the plasma membrane, detected by surface membrane immunostaining, nor reduced production of intracellular infectious viral progeny. Release of infectious virus, on the other hand, was impaired.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Chloromethyl Ketones / pharmacology*
  • Amino Acid Sequence
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Cytomegalovirus / drug effects*
  • Cytomegalovirus / growth & development
  • Cytomegalovirus / ultrastructure
  • Endopeptidases / metabolism
  • Fibroblasts / drug effects
  • Fibroblasts / microbiology
  • Fibroblasts / ultrastructure
  • Humans
  • Molecular Sequence Data
  • Palmitates / pharmacology*
  • Viral Envelope Proteins / metabolism*
  • Virus Replication

Substances

  • Amino Acid Chloromethyl Ketones
  • Palmitates
  • Viral Envelope Proteins
  • glycoprotein B, Simplexvirus
  • Endopeptidases